Abstract
Purpose of Review
The purpose of this review is to summarize the newest generation of quantitative neuromuscular monitors and the different modalities that can be used to minimize the risk of postoperative residual weakness.
Recent Findings
New guidelines and consensus statements are emerging that emphasize the importance of using quantitative monitors whenever neuromuscular blocking agents (NMBAs) are administered. Additionally, there are new technologies emerging in this area.
Summary
Residual neuromuscular blockade remains a common occurrence in the postoperative period. Even small degrees of residual muscle weakness can produce significant postoperative complications. Qualitative (subjective) assessment is an unacceptable technique to exclude residual neuromuscular blockade because fade is difficult to detect when train-of-four ratios are between 0.4 and 0.9. For that reason, using objective quantitative monitors is essential to confirm adequate recovery in all patients receiving NMBAs and ensure patient safety.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Lieutaud T, Billard V, Khalaf H, Debaene B. Muscle relaxation and increasing doses of propofol improve intubating conditions. Can J Anaesth. 2003;50(2):121–6.
Blobner M, Frick CG, Stäuble RB, Feussner H, Schaller SJ, Unterbuchner C, et al. Neuromuscular blockade improves surgical conditions (NISCO). Surg Endosc. 2015;29(3):627–36.
Griffith H, Johnson G. The use of curare in general anesthesia. Anesthesiology. 1942;3(4):418–20.
Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert PK, et al. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology. 2003;98(5):1049–56.
Bruintjes MH, van Helden EV, Braat AE, Dahan A, Scheffer GJ, van Laarhoven CJ, et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth. 2017;118(6):834–42.
Madsen MV, Staehr-Rye AK, Gatke MR, Claudius C. Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiol Scand. 2015;59(1):1–16.
Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010;111(1):120–128.
Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001;56(4):312–8.
Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98(5):1042–8.
Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997;87(5):1035–43.
Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology. 2009;110(6):1253–60.
Eriksson LI. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand. 1996;40(5):520–3.
•• Naguib M, Brull SJ, Kopman AF, Hunter JM, Fulesdi B, Arkes HR, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg. 2018;127(1):71–80 A recent consensus statement from the US on indications for and proper use of neuromuscular monitors.
•• Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2016;71(1):85–93 A recent consensus from Great Britain and Ireland providing guidance on the minimum standards for physiological monitoring of any patient undergoing anesthesia or sedation.
Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jorgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63(4):440–3.
Brull SJ, Silverman DG. Visual and tactile assessment of neuromuscular fade. Anesth Analg. 1993;77(2):352–5.
Brull SJ, Silverman DG. Real time versus slow-motion train-of-four monitoring: a theory to explain the inaccuracy of visual assessment. Anesth Analg. 1995;80(3):548–51.
Capron F, Fortier LP, Racine S, Donati F. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-hertz tetanus, 100-hertz tetanus, and acceleromyography. Anesth Analg. 2006;102(5):1578–84.
Claudius C, Skovgaard LT, Viby-Mogensen J. Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized-controlled trial. Acta Anaesthesiol Scand. 2009;53(4):449–54.
Infinity Trident NMT SmartPod. Dräger website. [cited; Available from: https://www.draeger.com/Products/Content/infinity-trident-nmt-smartpod-pi-9002487-en-us.pdf.
IntelliVue NMT module. Philips website. [cited; Available from: www.philips.com/nmtmodule.
Dubois V, Fostier G, Dutrieux M, Jamart J, Collet S, de Dorlodot C, et al. Philips Intellivue NMT module: precision and performance improvements to meet the clinical requirements of neuromuscular block management. J Clin Monit Comput. 2019.
Claudius C, Skovgaard LT, Viby-Mogensen J. Is the performance of acceleromyography improved with preload and normalization? A comparison with mechanomyography. Anesthesiology. 2009;110(6):1261–70.
TOF Scan. Dräger website. [cited; Available from: https://www.draeger.com/en_aunz/Hospital/Products/Patient-Monitoring/Patient-Monitoring-Pods/TOFscan.
Kopman AF, Kopman DJ. An analysis of the TOF-watch algorithm for modifying the displayed train-of-four ratio. Acta Anaesthesiol Scand. 2006;50(10):1313–4.
Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur M, et al. Comparison of the TOFscan and the TOF-watch SX during recovery of neuromuscular function. Anesthesiology. 2018;129(5):880–8.
Colegrave N, Billard V, Motamed C, Bourgain JL. Comparison of the TOF-Scan acceleromyograph to TOF-watch SX: influence of calibration. Anaesth Crit Care Pain Med. 2016;35(3):223–7.
Stimpod NMS450 Peripheral Nerve Stimulator.XAvant Technology website. [cited; Available from: http://www.xavant.com/products.
Stimpod NMS450. Precision Nerve Locator. XAvant Technology website. [cited; Available from: https://www.xavant.com/products/stimpod-nms410/.
Hyman EC, Brull SJ. Clarification: current status of neuromuscular reversal and monitoring. Challenges and Opportunities Anesthesiology. 2017;127(4):730.
TetraGraph. Senzime website. [cited; Available from: https://www.senzime.com/tetragraph/.
TwitchView. Blink Device Company [cited; Available from: https://www.blinkdc.com/twitchview.
Bowdle A, Bussey L, Michaelsen K, Jelacic S, Nair B. Togashi K, et al. Anaesthesia: A comparison of a prototype electromyograph vs. a mechanomyograph and an acceleromyograph for assessment of neuromuscular blockade; 2019.
E-NMT module. GE Healthcare website. [cited; Available from: www.gehealthcare.com.
Stewart PA, Freelander N, Liang S, Heller G, Phillips S. Comparison of electromyography and kinemyography during recovery from non-depolarising neuromuscular blockade. Anaesth Intensive Care. 2014;42(3):378–84.
Murphy GS. Neuromuscular monitoring in the perioperative period. Anesth Analg. 2018;126(2):464–8.
Dutu M, Ivascu R, Tudorache O, Morlova D, Stanca A, Negoita S, et al. Neuromuscular monitoring: an update. Rom J Anaesth Intensive Care. 2018;25(1):55–60.
TOF-Cuff. RGB Medical Devices, S.A. Spain [cited; Available from: http://www.rgb-medical.com/en/special-product/tof-cuff-nmt-monitor.
Rodiera J, Serradell A, Alvarez-Gomez JA, Aliaga L. The cuff method: a pilot study of a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand. 2005;49(10):1552–8.
Veiga Ruiz G, Garcia Cayuela J, Orozco Montes J, Parreno Caparros M, Garcia Rojo B, Aguayo Albasini JL. Monitoring intraoperative neuromuscular blockade and blood pressure with one device (TOF-Cuff): a comparative study with mechanomyography and invasive blood pressure. Rev Esp Anestesiol Reanim. 2017;64(10):560–7.
Kazuma S, Wakasugi K, Hagiwara H, Yamakage M. Comparative study of TOF-cuff, a new neuromuscular blockade monitor, and TOF-Watch, an acceleromyography. Anesth Analg. 2019;129(1):e16–e9.
Krijtenburg P, Honing G, Martini C, Olofsen E, van Elst HJ, Scheffer GJ, et al. Comparison of the TOF-cuff((R)) monitor with electromyography and acceleromyography during recovery from neuromuscular block. Br J Anaesth. 2019;122(2):e22–e4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Vivian Hernandez-Torres declares that he has no conflict of interest. J. Ross Renew has received research support through a grant from Merck (with funds to Mayo Clinic).
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Neuromuscular Blockade
Rights and permissions
About this article
Cite this article
Hernandez-Torres, V., Renew, J.R. Detecting Residual Weakness: an Update on Quantitative Neuromuscular Monitoring. Curr Anesthesiol Rep 10, 117–122 (2020). https://doi.org/10.1007/s40140-020-00391-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40140-020-00391-9